Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...

Roche Holding reported positive Phase II results for its investigational obesity drug CT-388, showing robust efficacy and ...

Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...

The global immunoassay market is projected to expand at a compound annual growth rate (CAGR) of approximately 6–7% over the ...

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast ...

Roche Holding AG RHHBY announced positive top-line data from a mid-stage study of its investigational candidate, CT-388, being developed for the treatment of obesity. CT-388 is a once-weekly ...

In 2024, the microfluidics-based devices segment accounted for the largest market share of 70.5%. North America accounted for ...

Diagnostic Enzymes Research Report 2026 - Global $8.72 Bn Market Trends, Opportunities, And Forecasts To 2031. The Global Diagnostic Enzymes Market is driven by rising chronic disease prevalence ...

Iran pumps around 3.3 million barrels a day and exports roughly 1.5 million barrels a day. "This will be the most immediate supply concern," ING analysts say. Investors are also watching the Strait of ...

Swiss pharmaceutical manufacturer Roche reports phase 2 results for CT-388, pointing to possible expansion in the fast-growing weight-loss market ...

The picture across markets suggests a broad correction rather than panic. Prices are adjusting after rapid gains, risk ...